JP Morgan Chase
WHWK

JP Morgan Chase’s Whitehawk Therapeutics WHWK Stock Holding History

JP Morgan Chase’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.9K Buy
13,573
+13,452
+11,117% +$56K ﹤0.01% 6353
2026
Q1 		$397 Hold
121
– – ﹤0.01% 7198
2025
Q4 		$293 Sell
121
-300
-71% -$688 ﹤0.01% 7123
2025
Q3 		$800 Hold
421
– – ﹤0.01% 7004
2025
Q2 		$787 Sell
421
-1,341
-76% -$2.33K ﹤0.01% 6647
2025
Q1 		$3.14K Buy
1,762
+284
+19% +$742 ﹤0.01% 6491
2024
Q4 		$4.66K Sell
1,478
-2,759
-65% -$6.25K ﹤0.01% 6527
2024
Q3 		$8.73K Buy
4,237
+3,816
+906% +$6.17K ﹤0.01% 6391
2024
Q2 		$615 Sell
421
-6,573
-94% -$12.2K ﹤0.01% 6669
2024
Q1 		$16.4K Sell
6,994
-3,554
-34% -$6.85K ﹤0.01% 6264
2023
Q4 		$21.3K Hold
10,548
– – ﹤0.01% 6237
2023
Q3 		$51.1K Sell
10,548
-2,814
-21% -$16.4K ﹤0.01% 5803
2023
Q2 		$91.4K Buy
13,362
+2,234
+20% +$17.4K ﹤0.01% 5507
2023
Q1 		$80K Buy
11,128
+2,896
+35% +$30.9K ﹤0.01% 5523
2022
Q4 		$105K Buy
8,232
+319
+4% +$4.17K ﹤0.01% 5339
2022
Q3 		$112K Buy
7,913
+171
+2% +$2.25K ﹤0.01% 5240
2022
Q2 		$95K Buy
+7,742
New +$115K ﹤0.01% 5435
2020
Q4 		– Sell
-427
Closed -$10K – 5992
2020
Q3 		$10K Buy
+427
New +$8.98K ﹤0.01% 5262
2019
Q2 		– Sell
-320
Closed -$4K – 6056
2019
Q1 		$4K Buy
+320
New +$13.8K ﹤0.01% 5638

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase's WHWK Position: Q2 2026 in Review

JP Morgan Chase increased its Whitehawk Therapeutics (WHWK) stake by 11,117% in Q2 2026, buying an estimated $56K and bringing the position to 13,573 shares worth $59.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6353.

JP Morgan Chase first reported a position in WHWK in Q1 2019 and has held it in 19 quarters since. The position peaked at $112K in Q3 2022. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • JP Morgan Chase held 13,573 shares of Whitehawk Therapeutics worth $59.9K as of Q2 2026.
  • JP Morgan Chase bought 13,452 Whitehawk Therapeutics shares in Q2 2026, an estimated $56K.
  • Whitehawk Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6353 holding.
  • JP Morgan Chase first reported a position in Whitehawk Therapeutics in Q1 2019 and has held it in 19 quarters since.
  • JP Morgan Chase's Whitehawk Therapeutics position peaked at $112K in Q3 2022.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.